• Je něco špatně v tomto záznamu ?

EAHP European Statements Survey 2018, focusing on Section 1: Introductory Statements and Governance, Section 3: Production and Compounding, and Section 4: Clinical Pharmacy Services

S. Amann, J. Underhill, P. Horák, A. Batista, N. Miljkovic, N. Gibbons

. 2022 ; 29 (1) : 26-32. [pub] 20191202

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019521
E-zdroje Online Plný text

NLK PubMed Central od 2016
Europe PubMed Central od 2016 do Před 1 rokem
ProQuest Central od 2012-02-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2012-02-01 do Před 6 měsíci

OBJECTIVES: The 2018 EAHP European Statements Survey focused on sections 1, 3 and 4 of the European Statements of Hospital Pharmacy. Statistical data on the level of implementation and on the main barriers to implementation of the Statements were collected. A further aim was to identify barriers in general, such as lack of awareness. METHODS: An online questionnaire was sent to all hospital pharmacies in EAHP member countries. Data were analysed at Keele University School of Pharmacy, UK. As with previous reports, the survey was divided into three sections: section A, asking general questions about the hospital pharmacy; Section B, addressing questions about the current activity of pharmacists around each statement from Sections 1, 3 and 4; and Section C, focusing on their ability to implement the statements. RESULTS: 719 complete responses were obtained from a sample of 5164 hospital pharmacies, giving a response rate of 14% (719/5164). Section A results indicated that 45% (323/719) of responders worked in teaching hospitals, 79% (568/719) of hospital pharmacies had 10 or fewer pharmacists, and 48% (345/719) of hospital pharmacies served over 500 beds. Section B results found a high percentage of positive responses for activity in section 1 (introductory statements and governance) and section 3 (production and compounding). However, responses to questions in section 4 (clinical pharmacy services) were more variable, with 6 of the 15 questions being answered positively by less than half of respondents. The five questions that revealed the lowest implementation levels were then analysed in greater detail. These questions corresponded to Statements 4.4, 4.5, 4.8, 1.1, and 4.2, which need the greatest effort for implementation. The major identified barriers to implementation were 'lack of capacity' and that 'other health professionals in the hospital fulfil the tasks'. CONCLUSIONS: This survey provides useful information on the implementation status (and the barriers to, and drivers of implementation) of sections 1, 3 and 4 of the Statements. This will allow the EAHP to plan its implementation support programme for its members. To increase the quality of data, as well as the feedback to hospital pharmacies, the EAHP is planning to combine the survey with the self-assessment tool of the European Statements of Hospital Pharmacy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019521
003      
CZ-PrNML
005      
20220804135730.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ejhpharm-2019-002028 $2 doi
035    __
$a (PubMed)34930791
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Amann, Steffen $u Krankenhausapotheke (Hospital Pharmacy), Stadtisches Klinikum Munchen GmbH, Munchen, Germany amann@adka.de
245    10
$a EAHP European Statements Survey 2018, focusing on Section 1: Introductory Statements and Governance, Section 3: Production and Compounding, and Section 4: Clinical Pharmacy Services / $c S. Amann, J. Underhill, P. Horák, A. Batista, N. Miljkovic, N. Gibbons
520    9_
$a OBJECTIVES: The 2018 EAHP European Statements Survey focused on sections 1, 3 and 4 of the European Statements of Hospital Pharmacy. Statistical data on the level of implementation and on the main barriers to implementation of the Statements were collected. A further aim was to identify barriers in general, such as lack of awareness. METHODS: An online questionnaire was sent to all hospital pharmacies in EAHP member countries. Data were analysed at Keele University School of Pharmacy, UK. As with previous reports, the survey was divided into three sections: section A, asking general questions about the hospital pharmacy; Section B, addressing questions about the current activity of pharmacists around each statement from Sections 1, 3 and 4; and Section C, focusing on their ability to implement the statements. RESULTS: 719 complete responses were obtained from a sample of 5164 hospital pharmacies, giving a response rate of 14% (719/5164). Section A results indicated that 45% (323/719) of responders worked in teaching hospitals, 79% (568/719) of hospital pharmacies had 10 or fewer pharmacists, and 48% (345/719) of hospital pharmacies served over 500 beds. Section B results found a high percentage of positive responses for activity in section 1 (introductory statements and governance) and section 3 (production and compounding). However, responses to questions in section 4 (clinical pharmacy services) were more variable, with 6 of the 15 questions being answered positively by less than half of respondents. The five questions that revealed the lowest implementation levels were then analysed in greater detail. These questions corresponded to Statements 4.4, 4.5, 4.8, 1.1, and 4.2, which need the greatest effort for implementation. The major identified barriers to implementation were 'lack of capacity' and that 'other health professionals in the hospital fulfil the tasks'. CONCLUSIONS: This survey provides useful information on the implementation status (and the barriers to, and drivers of implementation) of sections 1, 3 and 4 of the Statements. This will allow the EAHP to plan its implementation support programme for its members. To increase the quality of data, as well as the feedback to hospital pharmacies, the EAHP is planning to combine the survey with the self-assessment tool of the European Statements of Hospital Pharmacy.
650    _2
$a lidé $7 D006801
650    12
$a lékárny $7 D010594
650    _2
$a farmaceuti $7 D010595
650    12
$a farmacie $7 D010604
650    12
$a nemocniční lékárny $7 D010607
650    _2
$a průzkumy a dotazníky $7 D011795
655    _2
$a časopisecké články $7 D016428
700    1_
$a Underhill, Jonathan $u Keele University Centre for Medicines Optimisation, Keele University, Keele, Staffordshire, UK
700    1_
$a Horák, Petr $u Hospital Pharmacy, Motol University Hospital, Praha, Praha, Czech Republic
700    1_
$a Batista, Aida $u hospitalar, V.N. de Gaia, Portugal
700    1_
$a Miljkovic, Nenad $u Hospital Pharmacy, Institute for orthopaedic surgery Banjica, Beograd, Serbia
700    1_
$a Gibbons, Nicholas $u Centre for Medicines Optimisation, Keele University, Keele, Staffs, UK
773    0_
$w MED00200143 $t European journal of hospital pharmacy : science and practice $x 2047-9956 $g Roč. 29, č. 1 (2022), s. 26-32
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34930791 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135723 $b ABA008
999    __
$a ok $b bmc $g 1822923 $s 1170764
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 29 $c 1 $d 26-32 $e 20191202 $i 2047-9956 $m European journal of hospital pharmacy $n Eur J Hosp Pharm $x MED00200143
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...